 | Up a level |
Gomaa, M. S., Lim, A. S., Wilson Lau, S. C., Watts, A. M., Illingworth, N A, Bridgens, C. E., Veal, G. J., Redfern, C. P., Brancale, A, Armstrong, Jane and Simons, C. (2012) Synthesis and CYP26A1 inhibitory activity of novel methyl 3-[4-(arylamino)phenyl]-3-(azole)-2,2-dimethylpropanoates. Bioorganic & Medicinal Chemistry, 20 (20). pp. 6080-6081. ISSN 0968-0896
Gomaa, M., Bridgens, C., Illingworth, N., Veal, G. J., Redfern, C. P. F., Brancale, A, Armstrong, Jane and Simons, C. (2012) Novel retinoic acid 4-hydroxylase (CYP26) inhibitors based on a 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-(4-(phenyl-2-ylamino)phenyl)propyl scaffold. Bioorganic & Medicinal Chemistry, 20 (14). pp. 4201-4207. ISSN 0968-0896
Gomaa, M, Bridgens, C, Brancale, A, Veal, G J, Redfern, C P F, Armstrong, Jane and Simons, C (2011) Synthesis and Biological Evaluation of 3-(1H-Imidazol- and Triazol-1-yl)-2,2-Dimethyl-3-[4-(Naphthalen-2-ylamino)phenyl]propyl Derivatives as Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26). Journal of Medicinal Chemistry, 54 (19). pp. 6803-6811. ISSN 0022-2623
Gomaa, M, Bridgens, C, Aboraia, A S, Veal, G J, Redfern, C P F, Brancale, A, Armstrong, Jane and Simons, C (2011) Small MolecuImidazole Methyl 3-(4-(aryl-2-ylamino)phenyl)propanoates. Journal of Medicinal Chemistry, 54 (8). pp. 2778-2791. ISSN 0022-2623
Gomaa, M, Armstrong, Jane, Bobillon, B, Veal, G, Brancale, A, Redfern, C and Simons, C (2007) Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: Potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells. Bioorganic & Medicinal Chemistry, 16. pp. 8301-8313. ISSN 0968-0896